January 11, 2021
EQRx: Affordable Medicine When Patients Need It Most
In the summer of 2019, I was at a board offsite for Relay Therapeutics, chatting with long-time collaborator, investor, entrepreneur, and friend Alexis Borisy. Many who know Alexis acknowledge that he is seldom wrong, and never in doubt. He looked at me with all the conviction in the world to state point-blank that he wanted to tackle drug pricing.